Barco receives Frost & Sullivan's Customer Value Award for its 3D medical imaging software
KORTRIJK, Belgium, 13 July 2006 - Visualization specialist Barco is proud to announce that international growth consultant Frost & Sullivan has awarded the company with the Customer Value Award for VOXAR 3D, a portfolio of advanced visualization software and clinical applications. According to Frost & Sullivan, Barco's VOXAR 3D software provides customers with the best value for their investment in an advanced visualization solution for a PACS environment.
Barco's VOXAR 3D software offers exceptional value to hospital end-users who are looking to adopt advanced visualization capabilities as part of their radiology infrastructure. Frost & Sullivan granted the award to Barco because of VOXAR 3D's cost-effective deployment options, which provide unlimited access to advanced visualization toolsets and clinical application modules everywhere users need them throughout the hospital."Thanks to the sure-fire combination of value and user-friendliness, the VOXAR 3D software can be seamlessly and affordably integrated into a wide range of PACS architectures," says Martin Bryant, Team Leader, Medical Imaging, Healthcare (EMEA), Frost & Sullivan. "With Voxar 3D, there is no need to transfer image studies to a separate 3D workstation. This capability has brought tremendous workflow advantages to many hospitals, which has enhanced the reputation and acceptability of advanced visualization solutions within the medical community."
Frost & Sullivan also recognized the intrinsic customer value of the VOXAR 3D product features. Next to the immense benefit of a smooth PACS integration, which provides a seamless environment for the visualization of CT, MR and PET studies, VOXAR 3D has established itself through a dedicated response to end-user demands in terms of functionality. Thanks to the ease-of-use and intuitive operation of VOXAR 3D, users are much more productive when viewing and reading large cross-sectional image studies.
In addition, Barco received the Customer Value Award because it has extended the value of its VOXAR 3D software with the introduction of specific clinical applications. In 2005, Barco received FDA 510(k) clearance from the U.S. Food and Drug Administration for two innovative additions to the VOXAR 3D product line. VOXAR 3D VESSELMETRIX was approved for quantitative vessel analysis of CT and MR angiographic studies; VOXAR COLONSCREEN was approved for reading CT colonography studies of symptomatic and asymptomatic patients. These FDA approved clinical application modules add greater value to the VOXAR 3D product line by providing dedicated, clinical-focused tools for specific imaging applications.
With the recent introduction of VOXAR 3D V6.1, Barco continues to improve and innovate its 3D medical imaging software. First, VOXAR 3D v6.1 takes advantage of industry-leading graphics cards to further reduce reading time, improve performance and enhance usability. It also includes a suite of powerful CT cardiac applications. VOXAR 3D CARDIAMETRIX efficiently analyzes multi-phase cardiac CT studies. It delivers high-quality visualization of 2D, 3D and 4D cardiac images for quantitative evaluation of cardiac anatomy and function. Finally, VOXAR 3D v6.1 delivers a powerful, cost-effective solution for rapid, enterprise-wide access to advanced visualization. VOXAR 3D ENTERPRISE uses powerful client-server technology and graphics cards to accelerate the speed at which users can load, review, report and communicate large volumetric image studies throughout the hospital.
About Barco
Barco, a global technology company headquartered in Kortrijk, Belgium, designs and develops visualization products for a variety of professional markets. Barco has its own facilities for Sales & Marketing, Customer Support, R&D and Manufacturing in Europe, North America and Asia Pacific.
For fiscal year 2005, Barco posted net sales of euro 712.0 million.
Barco's ordinary shares are listed on the Brussels/Euronext stock exchange. Barco is a BEL 20 and a Next 150 company. Share information may be accessed on Bloomberg under the symbol BAR BB and on Reuters under BARBt.BR.
® Copyright 2006 by Barco - May be reproduced by professional press only
